A novel autophagy-related long non-coding RNAs signature predicting progression-free interval and I-131 therapy benefits in papillary thyroid carcinoma.

Hao, Jie; Wang, Shoujun; Wang, Jinmiao; Zhang, Zhendong; Gao, Ming; Wan, Yajuan

Hao, Jie; Wang, Shoujun; Wang, Jinmiao; Zhang, Zhendong; Gao, Ming; Wan, Yajuan.

Afiliación

Hao J; Department of Breast and Thyroid Surgery, Tianjin Union Medical Center of Nankai University, Tianjin, 300121, PR China.
Wang S; Tianjin Key Laboratory of General Surgery in Construction, Tianjin Union Medical Center, Tianjin, PR China.
Wang J; Department of Breast and Thyroid Surgery, Tianjin Union Medical Center of Nankai University, Tianjin, 300121, PR China.
Zhang Z; Tianjin Key Laboratory of General Surgery in Construction, Tianjin Union Medical Center, Tianjin, PR China.
Gao M; Department of Breast and Thyroid Surgery, Tianjin Union Medical Center of Nankai University, Tianjin, 300121, PR China.
Wan Y; Tianjin Key Laboratory of General Surgery in Construction, Tianjin Union Medical Center, Tianjin, PR China.

Open Med (Wars) ; 18(1): 20230660, 2023.

Article en En | MEDLINE | ID: mdl-36880066

Palabras clave

I-131 therapy; autophagy; lncRNAs; papillary thyroid carcinoma; progression-free interval

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Open Med (Wars) Año: 2023 Tipo del documento: Article Pais de publicación: Polonia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google